HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Steroid bills

This article was originally published in The Tan Sheet

Executive Summary

House Government Reform Committee Chairman Tom Davis (R-Va.) will introduce a bill the week of May 23 proposing a uniform drug testing policy for major professional sports leagues, including MLB, the NFL and the NBA. Co-authored by Rep. Henry Waxman (D-Calif.) and Sen. John McCain (R-Ariz.), the legislation likely will suggest similar penalties to Rep. Cliff Stearns' (R-Fla.) Drug Free Sports Act, which calls for minimum two-year bans for first offenses and lifetime bans for second offenses. The House Government Reform Committee held a hearing on the NBA's drug policy on the heels of an NFL meeting in April (1"The Tan Sheet" May 2, 2005, p. 14)...

You may also be interested in...



NFL Supplement Policy Not Hindered By Lack Of GMPs – Tagliabue

The absence of dietary supplement good manufacturing practices has had minimal impact on the National Football League's steroid policy, according to Commissioner Paul Tagliabue

WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency

The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.

Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector

With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS127156

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel